# STOCKHOLM 1.0
#=GF ID   PMM
#=GF AC   PF03332.17
#=GF DE   Eukaryotic phosphomannomutase
#=GF AU   Mifsud W;0000-0002-9805-6461
#=GF SE   Pfam-B_3713 (release 6.5)
#=GF GA   22.40 22.40;
#=GF TC   22.40 22.40;
#=GF NC   22.30 22.30;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Family
#=GF CL   CL0137
#=GF RN   [1]
#=GF RM   9878760
#=GF RT   The dolichol pathway of N-linked glycosylation. 
#=GF RA   Burda P, Aebi M; 
#=GF RL   Biochim Biophys Acta 1999;1426:239-257.
#=GF RN   [2]
#=GF RM   11530212
#=GF RT   Balancing N-linked glycosylation to avoid disease. 
#=GF RA   Freeze HH, Westphal V; 
#=GF RL   Biochimie 2001;83:791-799.
#=GF RN   [3]
#=GF RM   10571009
#=GF RT   Carbohydrate-deficient glycoprotein syndrome type IA
#=GF RT   (phosphomannomutase-deficiency). 
#=GF RA   Carchon H, Van Schaftingen E, Matthijs G, Jaeken J; 
#=GF RL   Biochim Biophys Acta 1999;1455:155-165.
#=GF DR   INTERPRO; IPR005002;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   This enzyme EC:5.4.2.8 is involved in the synthesis of the
#=GF CC   GDP-mannose and dolichol-phosphate-mannose required for a number
#=GF CC   of critical mannosyl transfer reactions.
#=GF SQ   8
#=GS PMM_DROME/32-254   AC Q9VTZ6.1
#=GS PMM_CAEEL/30-252   AC Q9XUE6.2
#=GS PMM2_HUMAN/28-246  AC O15305.1
#=GS PMM1_HUMAN/35-256  AC Q92871.2
#=GS PMM_ARATH/29-246   AC O80840.1
#=GS PMM_SCHPO/35-257   AC Q9UTJ2.1
#=GS PMM_CANAL/32-251   AC P31353.1
#=GS PMM_YEAST/35-254   AC P07283.1
PMM_DROME/32-254              FEEFFYSRVKPRATIGIVGGSDLEKMFEQLN...GRKILNEFDFIFPENGLVQIEGGKEVGKQNIIMHLGEETVKRFINFVLRYLSELDVPIKRGTFIEFRNGMMNVCPIGRQCTREERNMFAEYDIEHKVREKMIKDLKQEFADVDLTYSIGGQISFDVFPHGWDKTYCLRHIEAHYKFKEIHFFGDKTEPGGNDYEIYSDPRTISHRVYTPKDTQRILTEILEL
PMM_CAEEL/30-252              MREFLI.EARKRVPLAIVGGSDFKKITEQLADHDKDLLLSLFDYTFSENGLYGFKGTEPYPVQSIQKAIGDAKLQELINFALRYMSDIQLPVKRGNFVEFRNGMINLSPIGRSCSQEERMQFVEFDKKHGIRQKFTEQLREKFGQYGLQFAIGGQISVDVFPTGWDKTFCLQYLVPD..FDTIHFFGDKTAPGGNDHEIFADERTVGHTVEGPEDTRKHVENVLKE
PMM2_HUMAN/28-246             MDDFLQ.KLRQKIKIGVVGGSDFEKVQEQLG....NDVVEKYDYVFPENGLVAYKDGKLLCRQNIQSHLGEALIQDLINYCLSYIAKIKLPKKRGTFIEFRNGMLNVSPIGRSCSQEERIEFYELDKKENIRQKFVADLRKEFAGKGLTFSIGGQISFDVFPDGWDKRYCLRHVENDG.YKTIYFFGDKTMPGGNDHEIFTDPRTMGYSVTAPEDTRRIC.ELLFS
PMM1_HUMAN/35-256             VAAFLQ.KLRSRVQIGVVGGSDYCKIAEQLGD.G.DEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLRFSRGGMISFDVFPEGWDKRYCLDSLDQDS.FDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFP
PMM_ARATH/29-246              LLDFIR.ELRKVVTIGVVGGSDLSKISEQL....GKTVTNDYDYCFSENGLVAHKDGKSIGIQSLKLHLGDDKLKELINFTLHYIADLDIPIKRGTFIEFRNGMLNVSPIGRNCSQEERDEFERYDKVQNIRPKMVAELRERFAHLNLTFSIGGQISFDVFPKGWDKTYCLQYLED...FSEIHFFGDKTYEGGNDYEIYESPKTIGHSVTSPDDTVAKCKALFMS
PMM_SCHPO/35-257              MLETLQ.NLRKVVAIGFVGGSDLSKQQEQLSV.NGENVIDSFDYAFAENGLTAYRYGQQLASQSFIAWLGEEKYQKLVNFCLHYIADLDIPVKRGTFIEFRNGMINISPVGRNANTEERNEFERFDKGRKIRATMVDVLREKFKDYGLTFSIGGQISFDVFPAGWDKTYCLQHVEKEG.FDTIHFFGDKTYKGGNDYEIFVDPRTIGHSVTNPDDTIAELKKIFNI
PMM_CANAL/32-251              MKKTLE.KLREKVVIGFVGGSDLSKQVEQL....GPNVLNDFDYCFSENGLTAYKLGKELASQSFINWIGNEKYNKLVKFILRYLSDIDLPIRRGTFIEFRNGMINVSPIGRNASTQERNDYEKFDKQHHIRETMVEALKKEFPDFGLTYSIGGQISFDVFPTGWDKTYCLQHVEDEH.FENIHFFGDKSYKGGNDYEIYNDPRTIGHAVNSPDDTIRILNETFKL
PMM_YEAST/35-254              VRKTLA.KLRNKCCIGFVGGSDLSKQLEQL....GPNVLDEFDYSFSENGLTAYRLGKELASQSFINWLGEEKYNKLAVFILRYLSEIDLPKRRGTFLEFRNGMINVSPIGRNASTEERNEFERYDKEHQIRAKFVEALKKEFPDYGLTFSIGGQISFDVFPAGWDKTYCLQHVEKDG.FKEIHFFGDKTMVGGNDYEIFVDERTIGHSVQSPDDTVKILTELFNL
#=GC seq_cons                 hc-FLp.+LRp+VsIGlVGGSDLsKhtEQLs...GcsVlscFDYsFuENGLsAYKtGKpLupQSlhsaLGEEKlpcLINFsL+Ylu-lDLPlKRGTFIEFRNGMlNVSPIGRsCSpEERsEFpcaDKc+pIRpKhV-sL+cEFuchGLTFSIGGQISFDVFPsGWDKTYCLQHlEs-t.FcsIHFFGDKThsGGNDYEIFsDPRTIGHSVsoP-DTl+hlpElFp.
